Potassium channels, the cerebellum, and treatment for downbeat nystagmus.
Leigh
R John
RJ
D015761:4-Aminopyridine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000077770:Amifampridine; D006801:Humans; D008959:Models, Neurological; D009759:Nystagmus, Pathologic / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D026902:Potassium Channel Blockers / Q000627:therapeutic use*; D015221:Potassium Channels / Q000502:physiology; D011689:Purkinje Cells / Q000187:drug effects* / Q000502:physiology; D012021:Reflex, Abnormal / Q000187:drug effects; D012027:Reflex, Vestibulo-Ocular
D026902:Potassium Channel Blockers; D015221:Potassium Channels; D015761:4-Aminopyridine; D000077770:Amifampridine